REATA PHARMACEUTICALS INC Annual Return On Equity in % from 2017 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Reata Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2017 to 2022.
  • Reata Pharmaceuticals Inc Return On Equity for the quarter ending June 30, 2023 was 335 %.
  • Reata Pharmaceuticals Inc annual Return On Equity for 2022 was -923 %, a 773% decline from 2021.
  • Reata Pharmaceuticals Inc annual Return On Equity for 2021 was -106 %, a 13.5% decline from 2020.
  • Reata Pharmaceuticals Inc annual Return On Equity for 2020 was -93.2 %, a 87.9% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -923 -817 -773% Jan 1, 2022 Dec 31, 2022
2021 -106 -12.6 -13.5% Jan 1, 2021 Dec 31, 2021
2020 -93.2 +674 +87.9% Jan 1, 2020 Dec 31, 2020
2019 -767 -892 -714% Jan 1, 2019 Dec 31, 2019
2018 125 +98.8 +378% Jan 1, 2018 Dec 31, 2018
2017 26.1 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.